Home > Insider Trading > Filing (0001213900-25-015020)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
2028614	Drugs Made In America Acquisition Corp.	DMAA	Blank Checks (6770)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2038492	Drugs Made In America Acquisition Llc	1 East Broward Boulevard, Suite 700 Fort Lauderdale FL 33301		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2025-02-18	30,000	$0.00	4,188,780	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Rights to receive ordinary shares	Acquisiton	2025-02-18	30,000	$0.00	30,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
430,000			No	4	P	Direct

Footnotes

Reflects the 30,000 private units acquired by the reporting person, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-eighth (1/8) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $300,000.
The rights convert automatically into ordinary shares at the completion of the Issuer's initial business combination.